HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Elizabeth Arden Q1

This article was originally published in The Rose Sheet

Executive Summary

Net sales advanced 4.5% to $140.8 mil. in the first quarter fueled in part by "an increase in fragrance sales to mass retail customers" and "the launch of the Elizabeth Arden Provocative Woman fragrance," firm announces during May 3 analyst call. In-store promotional costs to support the new fragrance partially offset sales, the company adds. Arden's mass market business was up 11.3%. Cosmetics counters in department stores grew 19%, firm notes. Arden experienced a net loss of $13.7 mil. versus $16.7 mil. in the year-ago period. Firm also announces it will shift its fiscal year end from Jan. 31 to June 30, a move that will allow Arden to "provide more predictable earnings between fiscal quarters," according to the company. As a result, the firm will report financial results in August for the five-month period beginning Feb. 1, 2004 and ending June 30, 2004 as a transition period. Arden's 2005 fiscal year will begin July 1, 2004 and end June 30, 2005...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012184

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel